EyePoint Pharmaceuticals
$10.539876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$10.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.22 (-1.99%) Today
-$0.28 (-2.58%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell EYPT and other stocks, options, and ETFs commission-free!
About EYPT
EyePoint Pharmaceuticals, Inc. Common Stock, also called EyePoint Pharmaceuticals, is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA. The listed name for EYPT is EyePoint Pharmaceuticals, Inc. Common Stock.
CEO
Nancy Sue Lurker
Employees
84
Headquarters
Watertown, Massachusetts
Founded
1987
Market Cap
313.37M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
357.93K
High Today
$11.14
Low Today
$10.40
Open Price
$11.03
Volume
326.25K
52 Week High
$15.06
52 Week Low
$0.3511
EYPT Earnings
-$0.15
-$0.10
-$0.05
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Mar 4, Pre-Market